Haemonetics’ (HAE) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities reiterated their market outperform rating on shares of Haemonetics (NYSE:HAE – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a $100.00 price target on the medical instruments supplier’s stock. HAE has been the topic of several other reports. Wall Street Zen cut Haemonetics from a […]
JMP Securities reiterated their market outperform rating on shares of Haemonetics (NYSE:HAE – Free Report) in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has a $100.00 price target on the medical instruments supplier’s stock. HAE has been the topic of several other reports. Wall Street Zen cut Haemonetics from a […]
